icon
×

Dr. Praveen Adusumilli

Senior Consultant Medical & Hemato Oncology

Speciality

Medical Oncology

Qualification

MBBS, MD, DM (NIMS)

Experience

9 Years

Location

CARE Hospitals, HITEC City, Hyderabad

Best Medical & Hemato Oncologist in HITEC City

Brief Profile

Dr. Praveen Adusumilli is a highly experienced Best Medical & Hemato Oncologist in HITEC City with over 9 years of expertise in the diagnosis and treatment of solid tumors and blood cancers. As a Senior Consultant in Medical & Hemato Oncology at CARE Hospitals, HITEC City, Hyderabad, he is committed to delivering personalized, evidence-based cancer care using the latest advancements in medical oncology.

Dr. Praveen completed his MBBS, MD in General Medicine, and DM in Medical Oncology from the prestigious Nizam's Institute of Medical Sciences (NIMS), Hyderabad. His areas of expertise include immunotherapy, targeted therapy, stem cell transplantation, preventive oncology, clinical trials, and the management of thoracic, breast, gynecological, gastrointestinal, and hematological cancers. He believes in a multidisciplinary approach, developing individualized treatment plans to improve survival outcomes and enhance patients' quality of life.

An active researcher and academician, Dr. Praveen has authored multiple publications in reputed national and international oncology journals and is a member of prestigious organizations such as the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO). Patients seeking the Best Medical & Hemato Oncologist in HITEC City trust Dr. Praveen Adusumilli for his clinical expertise, compassionate care, and commitment to providing advanced cancer treatment tailored to every patient's needs.


Field(s) of Expertise

  • Immunotherapy
  • Targeted Therapy
  • Stem Cell Transplantation
  • Preventive Oncology
  • Clinical Trials
  • Thoracic, Gynaec, Breast, GI,  Haemato Oncology


Publications

  • Adusumilli P, Konatam ML, Gundeti S, Bala S, Maddali LS. Treatment Challenges and Survival Analysis of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the Real World. Indian Journal of Medical and Paediatric Oncology: Official Journal of Indian Society of Medical & Paediatric Oncology. 2017 Jan;38(1):22.
  • Adusumilli P, Gundeti S, K LS, Danthala M. Long-Term Survival and Late Side Effects of Paediatric Hodgkin Lymphoma Patients: A Study from a Tertiary Care Centre in Southern India. Annals of Oncology. 2015;26:89–89. doi:10.1093/annonc/mdv526.17.
  • Danthala M, Gundeti S, Kuruva SP, Puligundla KO, Adusumilli P, Karnam AP, Bala S, Konatam ML, Maddali LS, Digumarti RR. Generic Imatinib in Chronic Myeloid Leukemia: Survival of the Cheapest. Clinical Lymphoma, Myeloma & Leukemia. 2017 Jul;17(7):457–462.
  • Adusumilli P, Nayak L, Viswanath V, Digumarti L, Digumarti RR. Palliative Care and End-of-Life Measure Outcomes: Experience of a Tertiary Care Institute from South India. South Asian Journal of Cancer. 2018 Jul;7(3):210.


Education

  • M.B.B.S. (Bachelor of Medicine and Bachelor of Surgery), Siddhartha Medical College, Vijayawad, AP (2009)
  • MD (General Medicine), Alluri Sitarama Raju Institute of Medical Sciences, Eluru, AP (2014)
  • DM (Medical Oncology), Nizams Institute of Medical Sciences, Hyderabad


Languages Known

English, Telugu, Hindi


Fellowship/Membership

  • American Society of Clinical Oncology (ASCO),
  • European Society of Medical Oncology (ESMO)


Past Positions

  • Sr. Consultant Medical & Hemato Oncologist

Frequently Asked Questions

Still Have a Question?

If you cannot find answers to your queries, please fill out the enquiry form or call the number below. We will contact you shortly.

volume control phone icon +91-40-68106529